Company research
VSEE HEALTH, INC.
CIK 1864531Updated Sep 24, 2026
Name history
DIGITAL HEALTH ACQUISITION CORP. · through Jun 12, 2024
VSEE price & chart
Loading TradingView…
NASDAQ:VSEE on TradingView ↗About the company
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company’s offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.
In the news
No coverage from other publishers is available.
Recent filings
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 5.03, 9.01
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
8-K filing
Submission of Matters to a Vote of Security Holders
Items 5.07
10-Q filing
Show 5 more recent filings
SCHEDULE 13G/A filing
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02
DEF 14A filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 22,413,019Source | 78,588,364Source | 1,370,500Source | 7,634,367Source |
| Property, Plant and Equipment, NetUSD | 332,614Source | 883,323Source | 3,657Source | — |
| GoodwillUSD | 4,916,694Source | 61,591,904Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,785,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,266,286Source | — | 1,863Source | 106,998Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,520,844Source | 923,259Source | — | — |
| Assets, CurrentUSD | 8,365,407Source | 3,075,953Source | 1,863Source | 106,998Source |
| Prepaid Expense and Other Assets, CurrentUSD | 273,663Source | 260,789Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 13,304Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 16,960,651Source | 25,484,398Source | 12,354,400Source | 7,665,614Source |
| Commitments and ContingenciesUSD | 0Source | — | — | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 1Source | — | — | — |
| Common Stock, Value, IssuedUSD | 3,319Source | — | 350Source | 347Source |
| Additional Paid in CapitalUSD | 87,865,771Source | 63,675,694Source | 550,246Source | 292,973Source |
| Retained Earnings (Accumulated Deficit)USD | -82,416,723Source | -10,573,210Source | -12,816,453Source | -7,719,916Source |
| Stockholders' Equity Attributable to ParentUSD | — | — | -12,265,857Source | -7,426,596Source |
| Liabilities and EquityUSD | 22,413,019Source | 78,588,364Source | 1,370,500Source | 7,634,367Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 16,244,608Source | 24,119,693Source | 7,984,400Source | 3,295,614Source |
| Operating Lease, Liability, CurrentUSD | 10,394Source | — | — | — |
| Accounts Payable, CurrentUSD | 5,528,161Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 2,910Source | — | — | — |
| Deferred Income Tax Liabilities, NetUSD | 119,192Source | 67,378Source | — | — |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | 1,324,485Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | 119,192Source | — | — | — |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 1,241,996Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 593,941Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -14,712,850Source | -57,702,015Source | -4,413,866Source | -3,242,501Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,833,791Source | 1,094,190Source | — | — |
| Deferred Income Tax Expense (Benefit)USD | 51,814Source | -1,679,404Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -3,445,733Source | -5,789,542Source | -962,042Source | -1,391,213Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -29,928Source | -26,144Source | 6,517,499Source | 110,122,253Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 29,928Source | 55,267Source | — | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 44Source | — | 6,796,063Source | 110,472,254Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,415,832Source | 6,023,067Source | -5,660,592Source | -109,384,054Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 4,940,171Source | 207,381Source | -105,135Source | -653,014Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,266,286Source | 326,115Source | 1,863Source | 106,998Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 212,476Source | 111,331Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,124,519Source | 896,537Source | — | — |
| Amortization of Intangible AssetsUSD | 2,210,000Source | 1,105,000Source | — | — |
| DepreciationUSD | 33,614Source | 17,834Source | — | — |
| Financing Interest ExpenseUSD | 45,987Source | — | — | — |
| Gain (Loss) on Termination of LeaseUSD | -140,709Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -221,202Source | -645,979Source | — | — |
| General and Administrative ExpenseUSD | 10,037,275Source | 6,553,961Source | — | — |
| GoodwillUSD | 4,916,694Source | 4,916,694Source | — | — |
| Goodwill, Impairment LossUSD | 0Source | 56,675,210Source | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | — | — |
| Income Tax Expense (Benefit)USD | 68,426Source | -1,642,901Source | — | 187,225Source |
| InterestExpenseNonoperatingUSD | 2,811,861Source | 211,459Source | — | — |
| Investment Income, InterestUSD | — | — | 358,767Source | 922,644Source |
| Net Income (Loss) Attributable to ParentUSD | -14,712,850Source | -57,702,015Source | -4,413,866Source | -3,242,501Source |
| Nonoperating Income (Expense)USD | -5,061,531Source | 2,805,929Source | -1,820,101Source | 539,691Source |
| Operating Costs and ExpensesUSD | — | — | 2,593,765Source | 3,594,967Source |
| Operating ExpensesUSD | 16,938,858Source | 69,328,425Source | — | — |
| Operating Lease, ExpenseUSD | 115,116Source | 113,149Source | — | — |
| Other Nonoperating Income (Expense)USD | 47,429Source | 504Source | — | — |
| Payments of Financing CostsUSD | — | — | — | 61,800Source |
| Proceeds from Issuance of Common StockUSD | 1,500,003Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 14,618,184Source | 10,421,352Source | — | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -9,582,893Source | -62,150,845Source | -2,593,765Source | -3,594,967Source |
| Other Nonoperating Income (Expense)USD | 47,429Source | 504Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -14,644,424Source | -59,344,916Source | -4,413,866Source | -3,055,276Source |
| Income Tax Expense (Benefit)USD | 68,426Source | -1,642,901Source | — | 187,225Source |
| Net Income (Loss) Attributable to ParentUSD | -14,712,850Source | -57,702,015Source | -4,413,866Source | -3,242,501Source |
| Earnings Per Share, BasicUSD per share | -0.73Source | -5.65Source | -1.08Source | -0.25Source |
| Earnings Per Share, DilutedUSD per share | -0.73Source | -5.65Source | -1.08Source | -0.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 20,143,393Source | 10,213,036Source | 4,096,353Source | 12,741,219Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 20,143,393Source | 10,213,036Source | 4,096,353Source | 12,741,219Source |
| Interest Expense (non-operating)USD | 2,811,861Source | 211,459Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 2,210,000Source | 1,105,000Source | — | — |
| Business Combination, Acquisition Related CostsUSD | 0Source | 792,796Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 2,587,556Source | 1,323,467Source | — | — |
| Financing Interest ExpenseUSD | 45,987Source | — | — | — |
| General and Administrative ExpenseUSD | 10,037,275Source | 6,553,961Source | — | — |
| Goodwill, Impairment LossUSD | 0Source | 56,675,210Source | — | — |
| Gross ProfitUSD | 7,355,965Source | 7,177,580Source | — | — |
| Interest Expense, DebtUSD | — | — | — | 125,980Source |
| Investment Income, InterestUSD | — | — | 358,767Source | 922,644Source |
| Nonoperating Income (Expense)USD | -5,061,531Source | 2,805,929Source | -1,820,101Source | 539,691Source |
| Operating Costs and ExpensesUSD | — | — | 2,593,765Source | 3,594,967Source |
| Operating ExpensesUSD | 16,938,858Source | 69,328,425Source | — | — |
| Operating Lease, ExpenseUSD | 115,116Source | 113,149Source | — | — |
Offerings
Registration 333-292464
Filing attachments
vseeex99-1.htm · 8-K · 2026-06-05
EX-99.1 3 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Milton Chen, the Company’s co-Chief Executive Officer and Chairman of the Board and the Chief Executive Officer of VSee Lab, Inc., a Delaware Corporation and wholly-owned subsidiary of the Company (“VSee Lab”). Pu…
Read attachment ↗vseeex99-1.htm · 8-K · 2025-12-12
EX-99.1 2 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 SAN JOSE, CALIFORNIA / December 12, 2025 / VSee Health, Inc. (NASDAQ: VSEE) a leader in innovative telemedicine solutions, today announced that it anticipates that it will not have a sufficient number of shares of the Company’s common stock present in person or represented by proxy at the 2025 Annual Meeting of Stockholders (the “Annual Meet…
Read attachment ↗vseeex99-1.htm · 8-K/A · 2025-12-11
EX-99.1 2 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 September 30, Convertible Debt Transactions Warrant Conversion Transaction Pipe Investment Transaction Pro Forma December 31, …
Read attachment ↗vseeex99-1.htm · 8-K · 2025-11-28
EX-99.1 2 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 December 31, December 31, 2025 2024 ───────…
Read attachment ↗vseeex4-1.htm · 8-K · 2025-11-26
EX-4.1 2 vseeex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN A…
Read attachment ↗vseeex4-2.htm · 8-K · 2025-11-26
EX-4.2 3 vseeex4-2.htm EXHIBIT 4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN A…
Read attachment ↗